tRNA Fragments: Expression and Function in Ovarian Cancer
2017-09
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
tRNA Fragments: Expression and Function in Ovarian Cancer
Authors
Published Date
2017-09
Publisher
Type
Thesis or Dissertation
Abstract
Deep sequencing studies of noncoding RNA in liquid biopsies are revealing a vast repertoire of potential biomarkers. Ovarian cancer is a difficult-to-diagnose disease, urgently requiring novel and readily accessible biomarkers. We hypothesized that urine, one source of liquid biopsy samples, may contain novel noncoding RNAs (ncRNAs) that could serve as biomarkers for ovarian cancer. We proceeded to deep sequence RNA extracted from urine collected from ovarian cancer patients to better understand the repertoire of small RNAs in this type of liquid biopsy sample. The ncRNAs identified in these urine samples were predominantly microRNAs (miRNAs), ribosomal RNA (rRNA) fragments and tRNA fragments (tRFs). tRFs are a group of ncRNAs, which have been found across the biological kingdom and are increasingly being studied for their role in cancer biology. Several tRFs have been studied in cancer, although not previously in ovarian cancer. We have studied the expression of one specific tRF, 5’ fragment of tRNA-Glu-CTC (tRF5-Glu), in five different ovarian cancer cell lines. Several variants of tRF5-Glu were identified and we have now confirmed the expression of tRF5-Glu in ovarian cancer cells by quantitative real-time PCR (qRT-PCR), Northern analysis and ligation PCR. Additionally, we determined that angiogenin (ANG) plays a role in the biogenesis of tRF5-Glu. Furthermore, we have shown that tRF5-Glu targets the mRNA of the Breast Cancer Anti-estrogen Resistance 3 (BCAR3). While BCAR3 is known to regulate cancer cell migration and contributes to anti-estrogen resistance in breast cancer cells, it has not previously been studied in ovarian cancer or shown to be targeted by a tRF. Using synthetic mimics of tRF5-Glu and siRNAs targeting BCAR3, we were able to show that tRF5-Glu expression and the knock down of BCAR3 expression inhibits proliferation in ovarian cancer cells. These studies demonstrate that tRF5-Glu contributes to the regulation of BCAR3 and provides a novel mechanism of the regulation of proliferation in ovarian cancer cell lines.
Description
University of Minnesota Ph.D. dissertation.September 2017. Major: Biochemistry, Molecular Bio, and Biophysics. Advisors: Lester Drewes, Lynne Bemis. 1 computer file (PDF); xi, 127 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Zhou, Kun. (2017). tRNA Fragments: Expression and Function in Ovarian Cancer. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/191416.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.